table of content
1 Study Coverage
1.1 Sexual Dysfunction Drugs Product Introduction
1.2 Global Sexual Dysfunction Drugs Outlook 2017 VS 2022 VS 2028
1.2.1 Global Sexual Dysfunction Drugs Sales in US$ Million for the Year 2017-2028
1.2.2 Global Sexual Dysfunction Drugs Sales in Volume for the Year 2017-2028
1.3 United States Sexual Dysfunction Drugs Outlook 2017 VS 2022 VS 2028
1.3.1 United States Sexual Dysfunction Drugs Sales in US$ Million for the Year 2017-2028
1.3.2 United States Sexual Dysfunction Drugs Sales in Volume for the Year 2017-2028
1.4 Sexual Dysfunction Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Sexual Dysfunction Drugs in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Sexual Dysfunction Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Sexual Dysfunction Drugs Market Dynamics
1.5.1 Sexual Dysfunction Drugs Industry Trends
1.5.2 Sexual Dysfunction Drugs Market Drivers
1.5.3 Sexual Dysfunction Drugs Market Challenges
1.5.4 Sexual Dysfunction Drugs Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Sexual Dysfunction Drugs Market Segment by Type
2.1.1 Oral Therapy
2.1.2 Intracavernosal Therapy
2.1.3 Hormonal Therapy
2.1.4 Transurethral Therapy
2.2 Global Sexual Dysfunction Drugs Market Size by Type
2.2.1 Global Sexual Dysfunction Drugs Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Sexual Dysfunction Drugs Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Sexual Dysfunction Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Sexual Dysfunction Drugs Market Size by Type
2.3.1 United States Sexual Dysfunction Drugs Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Sexual Dysfunction Drugs Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Sexual Dysfunction Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by User
3.1 Sexual Dysfunction Drugs Market Segment by User
3.1.1 Male
3.1.2 Female
3.2 Global Sexual Dysfunction Drugs Market Size by User
3.2.1 Global Sexual Dysfunction Drugs Sales in Value, by User (2017, 2022 & 2028)
3.2.2 Global Sexual Dysfunction Drugs Sales in Volume, by User (2017, 2022 & 2028)
3.3.3 Global Sexual Dysfunction Drugs Average Selling Price (ASP) by User (2017, 2022 & 2028)
3.3 United States Sexual Dysfunction Drugs Market Size by User
3.3.1 United States Sexual Dysfunction Drugs Sales in Value, by User (2017, 2022 & 2028)
3.3.2 United States Sexual Dysfunction Drugs Sales in Volume, by User (2017, 2022 & 2028)
3.3.3 United States Sexual Dysfunction Drugs Average Selling Price (ASP) by User (2017, 2022 & 2028)
4 Global Sexual Dysfunction Drugs Competitor Landscape by Company
4.1 Global Sexual Dysfunction Drugs Market Size by Company
4.1.1 Top Global Sexual Dysfunction Drugs Manufacturers Ranked by Revenue (2021)
4.1.2 Global Sexual Dysfunction Drugs Revenue by Manufacturer (2017-2022)
4.1.3 Global Sexual Dysfunction Drugs Sales by Manufacturer (2017-2022)
4.1.4 Global Sexual Dysfunction Drugs Price by Manufacturer (2017-2022)
4.2 Global Sexual Dysfunction Drugs Concentration Ratio (CR)
4.2.1 Sexual Dysfunction Drugs Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Sexual Dysfunction Drugs in 2021
4.2.3 Global Sexual Dysfunction Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Sexual Dysfunction Drugs Manufacturing Base Distribution, Product Type
4.3.1 Global Sexual Dysfunction Drugs Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Sexual Dysfunction Drugs Product Type
4.3.3 Date of International Manufacturers Enter into Sexual Dysfunction Drugs Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Sexual Dysfunction Drugs Market Size by Company
4.5.1 Top Sexual Dysfunction Drugs Players in United States, Ranked by Revenue (2021)
4.5.2 United States Sexual Dysfunction Drugs Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Sexual Dysfunction Drugs Sales by Players (2020, 2021 & 2022)
5 Global Sexual Dysfunction Drugs Market Size by Region
5.1 Global Sexual Dysfunction Drugs Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Sexual Dysfunction Drugs Market Size in Volume by Region (2017-2028)
5.2.1 Global Sexual Dysfunction Drugs Sales in Volume by Region: 2017-2022
5.2.2 Global Sexual Dysfunction Drugs Sales in Volume Forecast by Region (2023-2028)
5.3 Global Sexual Dysfunction Drugs Market Size in Value by Region (2017-2028)
5.3.1 Global Sexual Dysfunction Drugs Sales in Value by Region: 2017-2022
5.3.2 Global Sexual Dysfunction Drugs Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Sexual Dysfunction Drugs Market Size YoY Growth 2017-2028
6.1.2 North America Sexual Dysfunction Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Sexual Dysfunction Drugs Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Sexual Dysfunction Drugs Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 China Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.3 Europe
6.3.1 Europe Sexual Dysfunction Drugs Market Size YoY Growth 2017-2028
6.3.2 Europe Sexual Dysfunction Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Sexual Dysfunction Drugs Market Size YoY Growth 2017-2028
6.4.2 Latin America Sexual Dysfunction Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Sexual Dysfunction Drugs Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Sexual Dysfunction Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Pfizer
7.1.1 Pfizer Corporation Information
7.1.2 Pfizer Description and Business Overview
7.1.3 Pfizer Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Pfizer Sexual Dysfunction Drugs Products Offered
7.1.5 Pfizer Recent Development
7.2 GlaxoSmithKline
7.2.1 GlaxoSmithKline Corporation Information
7.2.2 GlaxoSmithKline Description and Business Overview
7.2.3 GlaxoSmithKline Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2017-2022)
7.2.4 GlaxoSmithKline Sexual Dysfunction Drugs Products Offered
7.2.5 GlaxoSmithKline Recent Development
7.3 Merck
7.3.1 Merck Corporation Information
7.3.2 Merck Description and Business Overview
7.3.3 Merck Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Merck Sexual Dysfunction Drugs Products Offered
7.3.5 Merck Recent Development
7.4 Eli Lilly
7.4.1 Eli Lilly Corporation Information
7.4.2 Eli Lilly Description and Business Overview
7.4.3 Eli Lilly Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Eli Lilly Sexual Dysfunction Drugs Products Offered
7.4.5 Eli Lilly Recent Development
7.5 AbbVie
7.5.1 AbbVie Corporation Information
7.5.2 AbbVie Description and Business Overview
7.5.3 AbbVie Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2017-2022)
7.5.4 AbbVie Sexual Dysfunction Drugs Products Offered
7.5.5 AbbVie Recent Development
7.6 Bayer
7.6.1 Bayer Corporation Information
7.6.2 Bayer Description and Business Overview
7.6.3 Bayer Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Bayer Sexual Dysfunction Drugs Products Offered
7.6.5 Bayer Recent Development
7.7 Teva Pharmaceutical Industries
7.7.1 Teva Pharmaceutical Industries Corporation Information
7.7.2 Teva Pharmaceutical Industries Description and Business Overview
7.7.3 Teva Pharmaceutical Industries Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Teva Pharmaceutical Industries Sexual Dysfunction Drugs Products Offered
7.7.5 Teva Pharmaceutical Industries Recent Development
7.8 Takeda
7.8.1 Takeda Corporation Information
7.8.2 Takeda Description and Business Overview
7.8.3 Takeda Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Takeda Sexual Dysfunction Drugs Products Offered
7.8.5 Takeda Recent Development
7.9 Apricus Biosciences
7.9.1 Apricus Biosciences Corporation Information
7.9.2 Apricus Biosciences Description and Business Overview
7.9.3 Apricus Biosciences Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Apricus Biosciences Sexual Dysfunction Drugs Products Offered
7.9.5 Apricus Biosciences Recent Development
7.10 Emotional Brain
7.10.1 Emotional Brain Corporation Information
7.10.2 Emotional Brain Description and Business Overview
7.10.3 Emotional Brain Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2017-2022)
7.10.4 Emotional Brain Sexual Dysfunction Drugs Products Offered
7.10.5 Emotional Brain Recent Development
7.11 Ivix LLX
7.11.1 Ivix LLX Corporation Information
7.11.2 Ivix LLX Description and Business Overview
7.11.3 Ivix LLX Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2017-2022)
7.11.4 Ivix LLX Sexual Dysfunction Drugs Products Offered
7.11.5 Ivix LLX Recent Development
7.12 Leadiant Biosciences
7.12.1 Leadiant Biosciences Corporation Information
7.12.2 Leadiant Biosciences Description and Business Overview
7.12.3 Leadiant Biosciences Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2017-2022)
7.12.4 Leadiant Biosciences Products Offered
7.12.5 Leadiant Biosciences Recent Development
7.13 NexMed
7.13.1 NexMed Corporation Information
7.13.2 NexMed Description and Business Overview
7.13.3 NexMed Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2017-2022)
7.13.4 NexMed Products Offered
7.13.5 NexMed Recent Development
7.14 S1 Biopharma
7.14.1 S1 Biopharma Corporation Information
7.14.2 S1 Biopharma Description and Business Overview
7.14.3 S1 Biopharma Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2017-2022)
7.14.4 S1 Biopharma Products Offered
7.14.5 S1 Biopharma Recent Development
7.15 Vietstar Biomedical Research
7.15.1 Vietstar Biomedical Research Corporation Information
7.15.2 Vietstar Biomedical Research Description and Business Overview
7.15.3 Vietstar Biomedical Research Sexual Dysfunction Drugs Sales, Revenue and Gross Margin (2017-2022)
7.15.4 Vietstar Biomedical Research Products Offered
7.15.5 Vietstar Biomedical Research Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Sexual Dysfunction Drugs Industry Chain Analysis
8.2 Sexual Dysfunction Drugs Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Sexual Dysfunction Drugs Distributors
8.3 Sexual Dysfunction Drugs Production Mode & Process
8.4 Sexual Dysfunction Drugs Sales and Marketing
8.4.1 Sexual Dysfunction Drugs Sales Channels
8.4.2 Sexual Dysfunction Drugs Distributors
8.5 Sexual Dysfunction Drugs Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
